Carcinoid Syndrome

patient care perspectives

by Jonathan R. Strosberg, MD

Patients with neuroendocrine tumors (NETs) and carcinoid syndrome who are being treated with somatostatin analogue (SSA) therapy may still experien......READ MORE

patient care perspectives

by Timothy J. Hobday, MD

When carcinoid syndrome is the source of worsening symptoms such as diarrhea, options to regain control include making adjustments to the somatosta......READ MORE

patient care perspectives

by Timothy J. Hobday, MD

Our featured expert describes several key concepts in the management of carcinoid heart disease, including the benefits of early referral for speci......READ MORE

patient care perspectives

by Timothy J. Hobday, MD

Our featured expert, Timothy J. Hobday, MD, illustrates the utility of multidisciplinary care for patients with carcinoid syndrome and neuroendocri......READ MORE

patient care perspectives

by Lowell B. Anthony, MD, FACP

While some patients with carcinoid syndrome are well controlled on long-acting repeatable (LAR) depot somatostatin analogues (SSAs), others may ben......READ MORE